Contract awardedPCR and molecular diagnostic platforms

Bruker to supply mycobacterium genotype testing for Belfast TB lab

BSO Procurement and Logistics Service (PaLS) has chosen Bruker to supply genotype testing for mycobacterium. The work will serve the tuberculosis laboratory in Belfast Health and Social Care Trust's microbiology department.

The laboratory wants an automated molecular method for naming the mycobacterium species grown from positive cultures. Bruker's solution will take each sample from arrival to final identification, analysing results automatically and storing them digitally. The contract also covers reagents and consumables, upkeep of the equipment and training for staff.

The open tender drew one bid, with quality making up 30% of the assessment. Bruker was awarded £263,359 in June 2026, below the estimate of £366,588. The six-year contract will start in January 2027, with an option to extend by up to 24 months.

Alert me to similar tenders

Contract ends January 2033

What
PCR and molecular diagnostic platforms
Supplier
Bruker
Value
£263,359
How it was bought
Open procedure
1 bid
Dates and next
Jan 2027 to Jan 2033
Option to Jan 2035

How it was bought

4 official notices
  1. 11 Jul 2025Planning noticeFind a Tender
  2. 19 Mar 2026Tender noticeeTendersNI
  3. 23 Apr 2026Bids closed1 bid
  4. 7 Jul 2026Award noticeFind a Tender
  5. 17 Sep 2026Award noticeFind a Tender
  6. 12 Jan 2027Contract starts
  7. 11 Jan 2033Contract endsUp to Jan 2035 with extension

BSO Procurement and Logistics Service (PaLS) has bought this 4 times since 2021

Last bought
Jun 2026
Typical length
6 years
Typical value
£373,759
Suppliers used
6
AwardedContractWon byValue
Jun 2026This purchase6 yearsBruker£263,359
Jul 2024Locked5 yearsLocked£484,159
Nov 2023LockedLocked£1.96m
Feb 2022Locked7 yearsLocked£250,000

Suppliers BSO Procurement and Logistics Service (PaLS) has used

SupplierContractsValue
Bruker Won this one1£263,359
Locked1£250,000
Locked1·
Locked1·
Locked1·

and 1 more

See the contracts and who won them

Figures to 21 November 2026

How it compares

With every PCR and molecular diagnostic platforms award since 2021

Half of awards fall between £32,886 and £403,658Median £97,406

Awards
496
Firms that won them
82
Median award
£97,406
of 488 with a value
This award
Bigger than 70%
of them
Typical length
1 year
In Northern Ireland
21 awards

Bruker ranks 23rd of 82 firms for PCR and molecular diagnostic platforms awards since 2021.

RankFirmAwardsValue
1Locked103£31.8m
2Locked50£13.5m
3Locked45£97m
4Locked33£1.94m
5Locked24£105.1m
5Locked24£1.41m
23Bruker Won this one3£2.08m
See who wins this work

PCR and molecular diagnostic platforms at other buyers

BSO Procurement and Logistics Service (PaLS) has awarded 359 contracts since 2021.

See BSO Procurement and Logistics Service (PaLS)'s page

2 PCR and molecular diagnostic platforms tenders are open now

See them
More PCR and molecular diagnostic platforms contracts awarded in 2026